Literature DB >> 2443286

Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy.

J González-Cabrero1, J Egido, J Sancho, F Moldenhauer.   

Abstract

Patients with IgA nephropathy often present a large array of antibodies against diet antigens and this disease can be experimentally induced by alimentary antigens. In this report, we have described the isolation from a patient with IgA nephropathy of antibovine serum albumin (BSA)-antibody idiotypes that are specifically recognized by auto-and heteroantiidiotypic antibodies. The fact that antigen (BSA) but not monomeric or aggregated human IgG inhibited the binding of antiidiotypic antibodies to the idiotypes, suggested that the idiotypic determinants are in or near the antigen binding site and that it is not a rheumatoid factor. By means of the heteroantiidiotypic antibodies raised in rabbits we observed the presence of increased levels of shared idiotypes in serum and/or immune complexes (IC) of 48 out of 70 (68.5%) genetically unrelated patients with IgA nephropathy. The close correlation (P less than 0.005) between the presence of IgA-IC, measured by Raji cell assay, and the existence of high levels of serum idiotypes, suggest that a portion of circulating IC could consist of idiotype-antiidiotype. A strong concordance between the presence and levels of idiotypes and the clinical activity, as defined by the existence of haematuria, was also noted. The discrepancies and absence of correlation observed in our study among the levels of anti-BSA antibodies of different classes and serum levels of idiotypes, circulating IC and haematuria could suggest that the antibodies reacting with the heterologous antiidiotypic antibodies could be directed to other more pathogenic antigens than dietary antigens. All together, our results suggest that IgA nephropathy might belong to the group of diseases that occur in susceptible individuals with a limited potential in the immunological response repertoire.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443286      PMCID: PMC1542748     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

2.  Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent.

Authors:  C L Cambiaso; A Goffinet; J P Vaerman; J F Heremans
Journal:  Immunochemistry       Date:  1975-04

3.  Detection of specific antigen within circulating immune complexes: validation of the assay and its application to food antigen-antibody complexes formed in healthy and food-allergic subjects.

Authors:  R Paganelli; R J Levinsky; D J Atherton
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

4.  The occurrence of shared idiotypic specificity among the goat antibodies that distinguish human hemoglobin S from A.

Authors:  R D Schreiber; M Reichlin
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.

Authors:  N I Abdou; H Wall; H B Lindsley; J F Halsey; T Suzuki
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

6.  Milk precipitins, circulating immune complexes, and IgA deficiency.

Authors:  C Cunningham-Rundles; W E Brandeis; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Anti-idiotypic antibodies against the receptor antibodies in myasthenia gravis.

Authors:  A K Lefvert
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

8.  Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic antisera to human antitetanus antibodies.

Authors:  R S Geha; R P Weinberg
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

9.  Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.

Authors:  D Geltner; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation.

Authors:  M Goldman; L M Rose; A Hochmann; P H Lambert
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  6 in total

1.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.

Authors:  M Wettendorff; D Iliopoulos; M Tempero; D Kay; E DeFreitas; H Koprowski; D Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus.

Authors:  J Norris; M Pietropaolo
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy.

Authors:  J González-Cabrero; J Egido; F Mampaso; M C Rivas; L Hernando
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits.

Authors:  P Zarco; C Maestre; G Herrero-Beaumont; E González; R Garcia-Hoyo; F J Navarro; P Braquet; J Egido
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.

Authors:  Yusuke Suzuki; Keiichi Matsuzaki; Hitoshi Suzuki; Keiko Okazaki; Hiroyuki Yanagawa; Norio Ieiri; Mitsuhiro Sato; Toshinobu Sato; Yoshio Taguma; Joe Matsuoka; Satoshi Horikoshi; Jan Novak; Osamu Hotta; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2014-01-30       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.